Considering that serum ADIPOQ concentration and its skin expression were altered in obesity, these findings suggest that ADIPOQ’s effects on skin are at least in part regulated by the reduced expression of ADIPOR2. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.